All In MedTech

Company

Pfizer

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements.

Public

Listed

PFE

NYSE · PFIZER INC

Public float

$138.0B

Value of shares held by non-insiders on Jun 29, 2025

Revenue

$62.6B

Fiscal year ending Dec 31, 2025

Net income

$7.77B

Fiscal year ending Dec 31, 2025

R&D spending

$10.4B

Fiscal year ending Dec 31, 2025

Cash

$1.82B

As of Sep 27, 2026

Long-term debt

$60.0B

As of Sep 27, 2026

Shares outstanding

5699.9M

As of Oct 28, 2026

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2025––$9.68B–
2023––$30.8B–
2021––$997M–

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

The investor database is part of the paid tier

For Pfizer we have 2 shareholders with 5% or more.

It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

Latest FDA decisions

Search the Clearance Tracker

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar

22 more trials with a free account

Reports received

27

Received Nov 1, 2025 to Nov 19, 2026

Malfunction reports

0

0.0% of reports

Injury reports

26

96% of reports

Death reports

1

3.7% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 232000
Jan 2410200
Feb 246000
Mar 2410000
Apr 245100
May 240100
Jun 2481740
Jul 242110
Aug 242810
Sep 243000
Oct 2415100
Nov 242000
Dec 241200
Jan 255100
Feb 258100
Mar 253200
Apr 251100
May 2501210
Jun 250200
Jul 250100
Aug 250100
Sep 250100
Oct 251100
Nov 250510
Dec 250100
Jan 260000
Feb 260800
Mar 260100
Apr 260100
May 260200
Jun 260000
Jul 260200
Aug 260000
Sep 260000
Oct 260600
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

3 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.